Page last updated: 2024-11-02

pentamidine and Mouth Diseases

pentamidine has been researched along with Mouth Diseases in 1 studies

Pentamidine: Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.
pentamidine : A diether consisting of pentane-1,5-diol in which both hydroxyl hydrogens have been replaced by 4-amidinophenyl groups. A trypanocidal drug that is used for treatment of cutaneous leishmaniasis and Chagas disease.

Mouth Diseases: Diseases involving the MOUTH.

Research Excerpts

ExcerptRelevanceReference
"To report a case of perioral numbness associated with intravenous pentamidine."1.34Perioral numbness associated with intravenous pentamidine administration. ( Milligan, KS; Phillips, DL, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Milligan, KS1
Phillips, DL1

Other Studies

1 other study available for pentamidine and Mouth Diseases

ArticleYear
Perioral numbness associated with intravenous pentamidine administration.
    The Annals of pharmacotherapy, 2007, Volume: 41, Issue:1

    Topics: Female; Humans; Hypesthesia; Infusions, Intravenous; Middle Aged; Mouth Diseases; Pentamidine

2007